Boule Diagnostics AB (publ) (STO:BOUL)
Sweden · Delayed Price · Currency is SEK 5.14
-0.14 (-2.65%)
Jan 5, 2026, 11:24 AM CET
Boule Diagnostics AB Market Cap
Boule Diagnostics AB has a market cap or net worth of 205.04 million as of January 5, 2026. Its market cap has decreased by -41.72% in one year.
Market Cap
205.04M
Enterprise Value
389.84M
Revenue
512.66M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.14
Market Cap Chart
Since June 23, 2011, Boule Diagnostics AB's market cap has increased from 162.45M to 205.04M, an increase of 26.22%. That is a compound annual growth rate of 1.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 2, 2026 | 205.04M | 7.54% |
| Dec 30, 2025 | 190.67M | -45.32% |
| Dec 30, 2024 | 348.72M | -19.96% |
| Dec 29, 2023 | 435.71M | -25.70% |
| Dec 30, 2022 | 586.38M | -38.11% |
| Dec 30, 2021 | 947.53M | -17.98% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 113.87B |
| Getinge AB | 59.27B |
| Sectra AB | 46.16B |
| Camurus AB | 36.50B |
| Medicover AB | 32.01B |
| Asker Healthcare Group AB | 31.50B |
| BioArctic AB | 27.55B |
| Elekta AB | 21.68B |